Getein Biotech, Inc (603387.SS) Stock
—
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Ownership
About Getein Biotech, Inc
—
Getein Biotech, Inc (603387.SS) stock trades at $8.91 with a market capitalization of $4.95B. The stock is valued at a price-to-earnings (P/E) ratio of 16.54, price-to-book of 1.68, price-to-sales of 4.52. Over the past 52 weeks the stock has ranged between $7.37 and $11.42, and currently trades 22.0% below its 52-week high. It pays a dividend yielding 2.99%.
On profitability, Getein Biotech, Inc generates a return on equity (ROE) of 10.02%, an operating margin of 19.28%, a net profit margin of 27.06%.
Official website: www.getein.com.cn
Getein Biotech, Inc (603387.SS) — frequently asked questions
What is Getein Biotech, Inc (603387.SS) stock price today?
Getein Biotech, Inc (603387.SS) is currently trading at $8.91, down 0.78% today.
What is 603387.SS P/E ratio?
Getein Biotech, Inc's P/E ratio is 16.54. This is between 15x and 30x, around the typical market average of roughly 18-22x.
What is 603387.SS return on equity (ROE)?
Getein Biotech, Inc's return on equity (ROE) is 10.02%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.
What is Getein Biotech, Inc's market cap?
Getein Biotech, Inc has a market capitalization of $4.95B.
Does 603387.SS pay a dividend?
Yes. Getein Biotech, Inc currently yields 2.99%. Yield moves with the share price, so it changes daily even when the payment does not.
How much debt does 603387.SS carry?
Getein Biotech, Inc has a debt-to-equity ratio of 0.11. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 603387.SS's profit margin?
Getein Biotech, Inc reports a net profit margin of 27.06% — the share of revenue left after every cost, including tax and interest.
What sector is 603387.SS in?
Getein Biotech, Inc is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 603387.SS listed on?
Getein Biotech, Inc trades on SHH under the ticker 603387.SS.
What is 603387.SS's 52-week range?
Over the last year Getein Biotech, Inc has traded between $7.37 and $11.42.
Related — Stocks
Popular Stocks
Screens 603387.SS currently matches
On the figures above, Getein Biotech, Inc passes the filters for 15 of our ready-made screens, among them Dividend Stocks, Low Debt Dividend Stocks, Low Debt Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.